MabThera (NHL/CLL) (rituximab)

MabThera (NHL/CLL) (rituximab)

MABTHERA is used to treat non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. MabThera may be used on its own or together with chemotherapy.

Patients
Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

MabThera (RA/GPA/MPA) (rituximab)

MabThera (RA/GPA/MPA) (rituximab)

MABTHERA is used to treat rheumatoid arthritis (RA), Granulomatosis with polyangiitis (Wegener's) (GPA) and Microscopic polyangiitis (MPA). 

Patients
Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

MabThera SC (rituximab) (NHL/CLL)

MabThera SC (rituximab) (NHL/CLL)

MabThera SC is a subcutaneous (under the skin) injection used to treat certain types of non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukaemia (CLL). MabThera SC may be used on its own or together with chemotherapy.

Patients
Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)